Ms Michelle Anne Reiner, OTRL,CHT in Plymouth, MN - Medicare Occupational Therapy Provider

Ms Michelle Anne Reiner, OTRL,CHT is a medicare enrolled "Occupational Therapist - Hand" provider in Plymouth, Minnesota. She graduated from medical school in 1983 and has 41 years of diverse experience with area of expertise as Occupational Therapy. She is a member of the group practice Infinite Health Collaborative Pa and her current practice location is 2855 Campus Dr Ste 300, Plymouth, Minnesota. You can reach out to her office (for appointments etc.) via phone at (763) 520-7870.

Ms Michelle Anne Reiner is licensed to practice in Minnesota (license number 100573) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1437225125.

Contact Information

	Ms Michelle Anne Reiner, OTRL,CHT
	2855 Campus Dr Ste 300, Plymouth, MN 55441
	(763) 520-7870
	(763) 520-7580

Healthcare Provider's Profile

Full Name	Ms Michelle Anne Reiner
Gender	Female
Speciality	Occupational Therapy
Experience	41 Years
Location	2855 Campus Dr Ste 300, Plymouth, Minnesota
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Ms Michelle Anne Reiner graduated from medical school in 1983

NPI Data:

NPI Number: 1437225125
Provider Enumeration Date: 11/27/2006
Last Update Date: 07/18/2018

Medicare PECOS Information:

PECOS PAC ID: 7517075856
Enrollment ID: I20111111000488

Medical Identifiers

Medical identifiers for Ms Michelle Anne Reiner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1437225125	NPI	-	NPPES
64-01458	Other	MN	MEDICA
27357RE	Other	MN	BLUE CROSS BLUE SHIELD
7382731-00	Other	MN	MEDICAL ASSISTANCE
HP15087	Other	MN	HEALTH PARTNERS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XH1200X	Occupational Therapist - Hand	100573 (Minnesota)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Infinite Health Collaborative Pa	1052225042	772

News Archive

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

Eli Lilly and Company and Incyte Corporation announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases. The lead compound, INCB28050, is currently being studied in a six-month dose-ranging Phase II trial for rheumatoid arthritis.

New questionnaire can predict people who engage in problematic behavior

Researchers in the social sciences have been searching for a holy grail: an accurate way to predict who is likely to engage in problematic behavior, like using drugs.

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.

Protein transporter in the gut could speed drug 'take up'

For poorly absorbed medications, drug makers should consider using natural homing devices to drive the drugs through the hazards of gastrointestinal acidity and enzymes to reach the bloodstream quicker, James Polli, PhD, said today at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in Atlanta.

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ms Michelle Anne Reiner allows following entities to bill medicare on her behalf.

Provider Name	Infinite Health Collaborative Pa
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1164474250 PECOS PAC ID: 1052225042 Enrollment ID: O20040209000574

News Archive

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

New questionnaire can predict people who engage in problematic behavior

Researchers in the social sciences have been searching for a holy grail: an accurate way to predict who is likely to engage in problematic behavior, like using drugs.

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.

Protein transporter in the gut could speed drug 'take up'

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Michelle Anne Reiner is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Michelle Anne Reiner, OTRL,CHT 4200 Dahlberg Dr Ste 300, Golden Valley, MN 55422-4841 Ph: (763) 520-7870	Ms Michelle Anne Reiner, OTRL,CHT 2855 Campus Dr Ste 300, Plymouth, MN 55441 Ph: (763) 520-7870

News Archive

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

New questionnaire can predict people who engage in problematic behavior

Researchers in the social sciences have been searching for a holy grail: an accurate way to predict who is likely to engage in problematic behavior, like using drugs.

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause.

Protein transporter in the gut could speed drug 'take up'

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Occupational Therapist in Plymouth, MN

Maggie Caroline Rees, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3021 Harbor Ln N Ste 120, Plymouth, MN 55447 Phone: 651-773-0354
Kelly Greeninger, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 220, Plymouth, MN 55446 Phone: 651-968-5600
Laura Solverson, MA, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14130 23rd Ave N, Plymouth, MN 55447 Phone: 763-383-7666 Fax: 763-383-6013
Bryn Elizabeth Wasserman, MA OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3001 Harbor Lane North, Suite 120, Plymouth, MN 55447 Phone: 651-773-0354 Fax: 651-773-0371
Sandra Hage, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4665 Deerwood Ln N, Plymouth, MN 55442 Phone: 612-508-3985
Kelly Ann Holden, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10713 32nd Ave N, Plymouth, MN 55441 Phone: 612-709-3102
Summer L Shepstone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14130 23rd Ave N, Plymouth, MN 55447 Phone: 312-238-1000

Ms Michelle Anne Reiner, OTRL,CHT - Medicare Occupational Therapist in Plymouth, MN

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

New questionnaire can predict people who engage in problematic behavior

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Protein transporter in the gut could speed drug 'take up'

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Medicare Reassignments

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

New questionnaire can predict people who engage in problematic behavior

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Protein transporter in the gut could speed drug 'take up'

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

New questionnaire can predict people who engage in problematic behavior

Current approach to drug discovery for Lou Gehrig's disease be re-examined

Protein transporter in the gut could speed drug 'take up'

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Occupational Therapist in Plymouth, MN